CD86 and ocular melanoma: Conversely, elevated CD19 on transitional B cells (OR = 1.099, 95% CI: 1.019–1.181, p = 0.018) after adjusting for IL-18 levels, and increased CD86+ plasmacytoid dendritic cell %Dendritic cell (OR = 1.109, 95% CI: 1.059–1.151, p < 0.001) after adjusting for IL-12 subunit B levels, were significantly associated with an increased risk of OM (Figure 3A).